Insider · CIK 0002033517
Paul Hideo Opgenorth
Files at EXOZ (EXOZYMES INC.). First filing -, latest -.
In brief
Paul Hideo Opgenorth files SEC Form 4 as officer at EXOZ (EXOZYMES INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Paul Hideo Opgenorth has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | EXOZ EXOZYMES INC. | AGrant or award COMMON STOCK | +3,999 | $8.44 | $34k | 645,149 | Apr 8, 2026 |
| Jun 13, 2025 | EXOZ EXOZYMES INC. | AGrant or award Common Stock | +2,990 | $12.54 | $37k | 641,150 | Jun 17, 2025 |
| Nov 8, 2024 | EXOZ EXOZYMES INC. | CConversion Common Stock | +2,344 | $6.40 | $15k | 640,504 | Nov 18, 2024 |
Questions about Paul Hideo Opgenorth
Answered from the filings on this page, as of the latest one.
Is Paul Hideo Opgenorth buying or selling?
Paul Hideo Opgenorth has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Paul Hideo Opgenorth's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul Hideo Opgenorth has 0.
Where does Paul Hideo Opgenorth file Form 4?
Paul Hideo Opgenorth has filed Form 4 at EXOZ (EXOZYMES INC.) as Vice President, Development. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.